SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: A special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma

American Journal of Surgical Pathology

Volumn 32, Issue 8, 2008, Pages 1168-1174

  Kohashi, Kenichi ^a   Oda, Yoshinao ^a   Yamamoto, Hidetaka ^a   Tamiya, Sadafumi ^a   Oshiro, Yumi ^b   Izumi, Teiyu ^a   Taguchi, Tomoaki ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

EWS; Extraskeletal myxoid chondrosarcoma; Fusion gene transcript; Rhabdoid; SMARCB1 INI1

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; PROTEIN SMARCB1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; NONHISTONE PROTEIN; ONCOPROTEIN; RNA BINDING PROTEIN EWS; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CHONDROSARCOMA; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EWING SARCOMA; GENE DELETION; GENE LOCATION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; CHEMISTRY; CLEAR CELL SARCOMA; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETICS; MORTALITY; MYXOSARCOMA; NEUROECTODERM TUMOR; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RHABDOID TUMOR; SARCOMA;

CHONDROSARCOMA; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA, MYXOID; NEUROECTODERMAL TUMORS, PRIMITIVE; ONCOGENE PROTEINS, FUSION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RHABDOID TUMOR; RNA-BINDING PROTEIN EWS; SARCOMA; SARCOMA, CLEAR CELL; SARCOMA, EWING'S; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 49249109215     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318161781a     Document Type: Article

References (34)

1. Antonescu C, Ladanyi M. Myxoid liposarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. WHO Classification of Tumours, Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARG Press; 2002:40-43.
2. Antonescu CR, Gerald W. Desmoplastic small round cell tumour. In: Fletcher CDM, Unni KK, Mertens F, eds. WHO Classification of Tumours, Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARG Press; 2002:216-218.
3. Aveyard JS, Knowles MA. Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification. J Mol Diagn. 2004;6:356-365.
4. Berggren P, Kumar R, Sakano S, et al. Detecting homozygous deletions in the CDKN2A[p16(INK4a)]/ARF[p14(ARF)] gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res. 2003;9:235-242.
5. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74-79.
6. Biegel JA, Tan L, Zhang F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res. 2002;8:3461-3467.
7. Bourdeaut F, Freneaux P, Thuille B, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007;211:323-330.
8. DeCristofaro MF, Betz BL, Wang W, et al. Alteration of hSNF5/ INI1/BAF47 detected in rhabdoid cell lines and primary rhabdo-myosarcomas but not Wilms' tumors. Oncogene. 1999;18: 7559-7565.
9. Donner LR, Wainwright LM, Zhang F, et al. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Hum Pathol. 2007;38:935-939.
10. Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer. 2003;3:685-694.
11. Hisaoka M, Hashimoto H. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol Int. 2005;55:453-463.
12. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004;28:1485-1491.
13. Imbalzano AN, Jones SN. Snf5 tumor suppressor couples chroma-tin remodeling, checkpoint control, and chromosomal stability. Cancer Cell. 2005;7:294-295.
14. Izumi T, Oda Y, Hasegawa T, et al. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod Pathol. 2006;19:820-831.
15. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol. 2004;28:644-650.
16. Kingston RE, Bunker CA, Imbalzano AN. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev. 1996;10:905-920.
17. Kinoshita Y, Shiratsuchi H, Tamiya S, et al. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis. J Cancer Res Clin Oncol. 2001;127:351-358.
18. Kohashi K, Oda Y, Yamamoto H, et al. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/ INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. J Cancer Res Clin Oncol. 2007;133: 817-824.
19. Kuroiwa K, Kinoshita Y, Shiratsuchi H, et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm. Histopathology. 2002;41:538-548.
20. Labuhn M, Jones G, Speel EJ, et al. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Oncogene. 2001;20:1103-1109.
21. Lucas DR, Heim S. Extraskeletal myxoid chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. WHO Classification of Tumours, Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARG Press; 2002:213-215.
22. Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005;65:4012-4019.
23. Oda Y, Tsuneyoshi M. Extrarenal rhabdoid tumors of soft tissue: Clinicopathological and molecular genetic review and distinction from other sort-tissue sarcomas with rhabdoid features. Pathol Int. 2006;56:287-295.
24. Ohali A, Avigad S, Cohen IJ, et al. High frequency of genomic instability in Ewing family of tumors. Cancer Genet Cytogenet. 2004;150:50-56.
25. Okamoto S, Hisaoka M, Ishida T, et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum Pathol. 2001;32:1116-1124.
26. Oshiro Y, Shiratsuchi H, Tamiya S, et al. Extraskeletal myxoid chondrosarcoma with rhabdoid features, with special reference to its aggressive behavior. Int J Surg Pathol. 2000;8:145-152.
27. Schofield D. Extrarenal rhabdoid tumour. In: Fletcher CDM, Unni KK, Mertens F, eds. WHO Classification of Tumours, Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARG Press; 2002:219-220.
28. Sciot R, Speleman F. Clear cell sarcoma of soft tissue. In: Fletcher CDM, Unni KK, Mertens F, eds. WHO Classification of Tumours, Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARG Press; 2002:211-212.
29. Sevenet N, Lellouch-Tubiana A, Schofield D, et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet. 1999;8:2359-2368.
30. Sigauke E, Rakheja D, Maddox DL, et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol. 2006;19:717-725.
31. Ueyama T, Nagai E, Yao T, et al. Vimentin-positive gastric carcinomas with rhabdoid features. A clinicopathologic and immunohistochemical study. Am J Surg Pathol. 1993;17:813-819.
32. Uno K, Takita J, Yokomori K, et al. Aberrations of the hSNF5/ INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Genes Chromosomes Cancer. 2002;34:33-41.
33. Ushigome S, Machinami R, Sorensen PH. Ewing sarcoma/Primitive neuroectodermal tumor (PNET). In: Fletcher CDM, Unni KK, Mertens F, eds. WHO Classification of Tumours, Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARG Press; 2002:298-300.
34. Vries RG, Bezrookove V, Zuijderduijn LM, et al. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev. 2005;19:665-670.